23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
85.01%
Revenue growth exceeding 1.5x Insurance - Life median of 0.92%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
85.01%
Gross profit growth of 85.01% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that could be built upon.
42.88%
Positive EBIT growth while Insurance - Life median is negative. Peter Lynch might see a strong competitive advantage in operations.
42.88%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
7.78%
Positive net income growth while Insurance - Life median is negative. Peter Lynch would view this as a notable competitive advantage.
7.78%
Positive EPS growth while Insurance - Life median is negative. Peter Lynch might see a strong advantage in per-share earnings compared to peers.
7.78%
Positive diluted EPS growth while Insurance - Life median is negative. Peter Lynch might see a real advantage in how this firm manages share count or drives net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.71%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-15.71%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
114.59%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 24.43%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
27.43%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 1.62%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
49.46%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 12.34%. Joel Greenblatt might see a short-term competitive advantage at play.
92.45%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 26.20% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
130.83%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 15.27%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
49.73%
3Y OCF/share growth > 1.5x Insurance - Life median of 1.76%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
0.88%
Net income/share CAGR of 0.88% while Insurance - Life median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
63.12%
Net income/share CAGR of 63.12% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
-13.99%
Negative 3Y CAGR while Insurance - Life median is -12.53%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
87.73%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
40.96%
5Y equity/share CAGR > 1.5x Insurance - Life median of 20.72%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
27.25%
3Y equity/share CAGR near Insurance - Life median. Charlie Munger notes it as typical short-term equity expansion in the sector.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
19.93%
AR growth of 19.93% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
2.76%
We expand assets while Insurance - Life is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
11.88%
BV/share growth of 11.88% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
0.82%
Debt growth of 0.82% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
-10.70%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.